Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ФГБОУ ВО «Ульяновский государственный университет», Ульяновск, Россия
Список исп. литературыСкрыть список 1. World Health Organization. WHO Manual for the Standardized Investigation and Diagnosis of the Infertile Couple. Cambridge: Cambridge University Press, 2000. 2. Tadros NN, Sabanegh ES. Empiric medical therapy with hormonal agents for idiopathic male infertility. Indian J Urol 2017; 33 (3): 194–98. 3. Jung JH, Seo JT. Empirical medical therapy in idiopathic male infertility: Promise or panacea? Clin Exp Reprod Med 2014; 41 (3): 108–14. 4. Ko EY, Siddiqi K, Brannigan RE, Sabanegh ES. Jr Empirical medical therapy for idiopathic male infertility: a survey of the American Urological Association. J Urol 2012; 187: 973–8. 5. Kumar R, Gautam G, Gupta NP. Drug therapy for idiopathic male infertility: rationale versus evidence. J Urol 2006; 176: 1307–12. 6. Schubert M, Pérez Lanuza L, Gromoll J. Pharmacogenetics of FSH Action in the Male. Front Endocrinol (Lausanne) 2019; 10: 47. 7. Blumenauer V, Czeromin U, Fiedler K et al. D.I.R. Annual 2014 – The German IVF-Registry. J Reproduktionsmed Endokinol 2015; 12: 509–45. 8. Esteves SC, Roque M, Bedoschi G et al. Intracytoplasmic sperm injection for male infertility and consequences for offspring. Nat Rev Urol 2018; 15: 535–62. 9. EAU Guidelines. Edn. presented at the EAU Annual Congress Milan. 2021. ISBN: 978-94-92671-13-4. 10. Agarwal A, Parekh N, Panner Selvam MK et al. Male Oxidative Stress Infertility (MOSI): Proposed Terminology and Clinical Practice Guidelines for Management of Idiopathic Male Infertility. World J Mens Health 2019; 37 (3): 296–312. 11. Atik RB, Christiansen OB, Elson J et al. ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open 2018; 2: hoy004. 12. McBride JA, Coward RM. Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use. Asian J Androl 2016; 18 (3): 373–80. 13. Wang G, Hardy MP. Development of Leydig cells in the insulin-like growth factor-I (igf-I) knockout mouse: effects of igf-I replacement and gonadotropic stimulation. Biol Reprod 2004; 70: 632–9. 14. Nieschlag E, Simoni M, Gromoll J, Weinbauer GF. Role of FSH in the regulation of spermatogenesis: clinical aspects. Clin Endocrinol 1999; 51: 139–46. 15. Dabaja AA, Schlegel PN. Medical treatment of male infertility. Transl Androl Urol 2014; 3 (1): 9–16. 16. Jarow JP, Zirkin BR. The androgen microenvironment of the human testis and hormonal control of spermatogenesis. Ann N Y Acad Sci 2005; 1061: 208–220. 17. Dohle GR, Smit M, Weber RF. Androgens and male fertility. World J Urol 2003; 21: 341–5. 18. Siegel ET, Kim HG, Nishimoto HK, Layman LC. The molecular basis of impaired follicle-stimulating hormone action: evidence from human mutations and mouse models. Reprod Sci 2013; 20: 211–33. 19. Santen RJ. Feedback control of luteinizing hormone and follicle-stimulating hormone secretion by testosterone and estradiol in men: physiological and clinical implications. Clin Biochem 1981; 14: 243–51. 20. Rittenberg V, El-Toukhy T. Medical treatment of male infertility. Hum Fertil (Camb) 2010; 13: 208–16. 21. Simoni M, Santi D. FSH treatment of male idiopathic infertility: Time for a paradigm change. Andrology 2020; 8 (3): 535–44. 22. Jan SZ, Hamer G, Repping S et al. Molecular control of rodent spermatogenesis. Biochim Biophys Acta 2012; 1822: 1838–50. 23. Knuth UA, Hönigl W, Bals-Pratsch M et al. Treatment of severe oligospermia with human chorionic gonadotropin/human menopausal gonadotropin: a placebo-controlled, double blind trial. J Clin Endocrinol Metab 1987; 65: 1081–7. 24. Kamischke A, Behre HM, Bergmann M et al. Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial. Hum Reprod 1998; 13: 596–603. 25. Paradisi R, Busacchi P, Seracchioli R et al. Effects of high doses of recombinant human follicle-stimulating hormone in the treatment of male factor infertility: Results of a pilot study. Fertil Steril 2006; 86: 728–31. 26. Attia AM, Abou-Setta AM, Al-Inany HG. Gonadotrophins for idiopathic male factor subfertility. Cochrane Libr 2013; 8: CD005071. 27. Colacurci N, De Leo V, Ruvolo G et al. Recombinant FSH Improves Sperm DNA Damage in Male Infertility: A Phase II Clinical Trial. Front Endocrinol (Lausanne) 2018; 9: 383. 28. Foresta C, Bettella A, Garolla A et al. Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study. Fertil Steril 2005; 84: 654–61. 29. Ramasamy R, Stahl PJ, Schlegel PN. Medical therapy for spermatogenic failure. Asian J Androl 2012; 14 (1): 57–60. 30. Santi D, Granata AR, Simoni M. FSH treatment of male idiopathic infertility improves pregnancy rate: a meta-analysis. Endocr Connect 2015; 4 (3): R46–R58. 31. Busch AS, Kliesch S, Tüttelmann F, Gromoll J. FSHB−211G>T stratification for follicle-stimulating hormone treatment of male infertility patients: making the case for a pharmacogenetic approach in genetic functional secondary hypogonadism. Andrology 2015; 3: 1050–3. 32. Simoni M, Casarini L. Mechanisms in endocrinology: geneticsof FSH action – A 2014-and-beyond view. Eur J Endocrinol 2014; 170: 91–107. 33. Chehab M, Madala A, Trussell JC. On-label and off-label drugs used in the treatment of male infertility. Fertil Steril 2015; 103: 595–604. 34. Vandekerckhove P, Lilford R, Vail A, Hughes E. Clomiphene or tamoxifen for idiopathic oligo/asthenospermia. Cochrane Database Syst Rev 1996; 4:CD000151. 35. A double-blind trial of clomiphene citrate for the treatment of idiopathic male infertility. World Health Organization. Int J Androl 1992; 15: 299–307. 36. Micic S, Dotlic R. Evaluation of sperm parameters in clinical trial with clomiphene citrate of oligospermic men. J Urol 1985; 133: 221–2. 37. Paulson DF. Clomiphene citrate in the management of male hypofertility: Predictors for treatment selection. Fertil Steril. 1977; 28:1226–1229. 38. Chua ME, Escusa KG, Luna S et al. Revisiting oestrogen antagonists (clomiphene or tamoxifen) as medical empiric therapy for idiopathic male infertility: a meta-analysis. Andrology 2013; 1: 749–57. 39. Delu A, Kiltz RJ, Kuznetsov VA, Trussell JC. Clomiphene citrate improved testosterone and sperm concentration in hypogonadal males. Syst Biol Reprod Med 2020; 66 (6): 364–9. 40. Gundewar T, Kuchakulla M, Ramasamy R. A paradoxical decline in semen parameters in men treated with clomiphene citrate: A systematic review. Andrologia 2021; 53 (1): e13848. 71. Roth LW, Ryan AR, Meacham RB. Clomiphene citrate in the management of male infertility. Semin Reprod Med 2013; 31 (4): 245–50. 42. Bharti S, Misro MM, Rai U. Clomiphene citrate potentiates the adverse effects of estrogen on rat testis and down-regulates the expression of steroidogenic enzyme genes. Fertil Steril 2013; 99: 140–8. 43. Clark RV, Sherins RJ. Treatment of men with idiopathic oligozoospermic infertility using the aromatase inhibitor, testolactone. Results of a double-blinded, randomized, placebo-controlled trial with crossover. J Androl 1989; 10: 240–7. 44. Pavlovich CP, King P, Goldstein M, Schlegel PN. Evidence of a treatable endocrinopathy in infertile men. J Urol 2001; 165: 837–41. 45. Raman JD, Schlegel PN. Aromatase inhibitors for male infertility. J Urol 2002; 167: 624–9. 46. Wickings EJ, Middleton MC, Hillier SG. Non-steroidal inhibition of granulosa cell aromatase activity in vitro. J Steroid Biochem 1987; 26 (6): 641–6. 47. Saylam B, Efesoy O, Cayan S. The effect of aromatase inhibitor letrozole on body mass index, serum hormones, and sperm parameters in infertile men. Fertil Steril 2011; 95: 809–11. 48. Shoshany O, Abhyankar N, Mufarreh N et al. Outcomes of anastrozole in oligozoospermic hypoandrogenic subfertile men. Fertil Steril 2017; 107 (3): 589–94. 49. Abel MH, Baker PJ, Charlton HM et al. Spermatogenesis and sertoli cell activity in mice lacking sertoli cell receptors for follicle-stimulating hormone and androgen. Endocrinology 2008; 149: 3279–85. 50. Sabanegh EJ, Agarwal A. Male infertility. In: Campbell MF, Walsh PC, Wein AJ, editors. Campbell-Walsh urology. 10th ed. Philadelphia: Saunders Elsevier, 2012. pp. 616–47. 51. Vandekerckhove P, Lilford R, Vail A, Hughes E. Androgens versus placebo or no treatment for idiopathic oligo/asthenospermia. Cochrane Database Syst Rev 1996; 18: CD000150. 52. de Souza GL, Hallak J. Anabolic steroids and male infertility: a comprehensive review. BJU Int 2011; 108: 1860–5.